x
We use our own and third-party cookies to improve our services. If you continue browsing, we assume that you accept its use.
Information about cookiesAccept cookiesDecline cookies
GP Pharm at the 30th ESPU Congress
GP Pharm at the 30th ESPU Congress

24-27 April, 2019

GP Pharm will present the results of the clinical study of the first Desmopressin in oral solution for paediatric use in plenary session.

Read more
GP Pharm at the 34th Annual EAU Congress (EAU19)
GP Pharm at the 34th Annual EAU Congress (EAU19)

15-19 March, 2019

Presentation of the clinical trial of GP Pharm’s Leuprolide acetate 22.5 mg recently approved by the FDA

Read more
Nit de CataloniaBio
Nit de CataloniaBio

15th March 2017

The networking-winter dinner of CataloniaBio 2017

Read more
CataloniaBio BBQ
CataloniaBio BBQ

20th July 2017

GP Pharm has been the gold sponsor of the CataloniaBio BBQ with a representation headed by Dr. Berta Ponsati, CEO of the company.

Read more
GP Pharm at the LXXXI Congreso Nacional de Urología
GP Pharm at the LXXXI Congreso Nacional de Urología

June 2016

GP Pharm was present in the LXXXI Congreso Nacional de Urología held in Toledo in June.

Read more
GP Pharm launches in Spain a new leuprolide formulation
GP Pharm launches in Spain a new leuprolide formulation

January 14th 2016

Lutrate® Depot

Read more
Lutrate® Trimestral
Lutrate® Trimestral

January 22nd 2016

Presentation Event

Read more
Back to Top